Impact of COVID-19 on Kidney Transplant Outcomes: An 8-Year Study From the Czech Republic

30 December 2025 : Original article

Jan Roman^{ABDEF 1,2}, František Jalůvka^{BDEF 1,2*}, Petr Jelínek

^{DEF 1,2}, Petr Ostruszka^{BF 1}, Ján Hrubovčák^{DEF 1,2}, Pavel Havránek^{ABD 1,3}, Adéla Kondé

^{CE 4,5}, Zdeněk Lys^{BCE 3}, Martin Drápela^{ABEF 3}, Vaclav Prochazka

^{AEF 2,6}

DOI: 10.12659/AOT.950961

Ann Transplant 2025; 30:e950961

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 Basic descriptive parameters of kidney recipients.

	Median (IQR) or n (%)*		P**
	Before COVID-19 (n=99)	COVID-19 pandemic (n=46)	P**
	54 (44; 63)	60 (48; 66)	0.174
	82 (74; 92)	82 (72; 91)	0.888
	26.7 (24.7; 29.7)	26.7 (25.1; 29.7)	0.610
	1.98 (1.86; 2.14)	1.98 (1.89; 2.09)	0.565
	73 (73.7)	32 (69.6)	0.746
^***	0.95 (0.86; 1.08)	1.00 (0.88; 1.08)	0.399
	13 (12; 16)	14 (8; 16)	0.779
^#	0 (0; 0)	0 (0; 0)	0.633
^#	0 (0; 0)	0 (0; 7)	0.728
	92 (92.9)	40 (87.0)	0.390
	24 (24.2)	10 (21.7)	0.904
	25 (25.3)	10 (21.7)	0.801
	8 (8.1)	5 (10.9)	0.829
	27 (27.3)	16 (34.8)	0.468
			0.850
0	77 (77.8)	35 (76.1)
1	21 (21.2)	10 (21.7)
2	1 (1.0)	1 (2.2)

Anti-CD25	24 (24.2)	21 (45.7)
ATG^##	28 (28.3)	21 (45.7)
Anti-CD25 + ATG^##	1 (1.0)	1 (2.2)
No	46 (46.5)	3 (6.4)

Chronic hemodialysis	83 (83.8)	34 (73.9)
Chronic peritoneal dialysis	11 (11.2)	2 (4.4)
Chronic combined dialysis	2 (2.0)	2 (4.3)
No	3 (3.0)	8 (17.4)
	22 (13; 30)	12 (7; 24)
^* The median with the interquartile range (Q1–Q3) or the absolute frequency and relative frequency (%). ^ The value of the Mann-Whitney test, chi-square test of independence for contingency tables, or Fisher’s exact test. ^* BSA – Body surface area according to the Mosteller calculation method. ^# PRA – Panel-reactive antibodies. ^## ATG – Antithymocyte globulin.

Back to the Article